RAD51C
- 总结
- RAD51C as a novel susceptibility gene for hereditary breast and ovarian cancer.
- 技术优势
- RAD51C as a novel susceptibility gene for hereditary: breast cancer, ovarian cancer, head and neck squamous cell carcinomas (HNSCC).
RAD51C as companion diagnostic for PARP or TOPO I Inhibitors.
- 技术应用
- Professional societies and health care systems, risk-adapted personalized treatment, identify individuals with germline and/or somatic mutation(s) in cancer risk genes
- 详细技术说明
- A novel susceptibility gene for hereditary cancers. RAD51C, which encodes for a protein involved in DNA repair, has been found to be mutated in families with breast and ovarian cancer, but not in healthy control subjects
- 合作类型
- Licensing
- 申请日期
- 09/04/2010 00:00:00
- 申请号码
- EP20100159524 20100409
- 分类
- - international:
C12Q1/68
- cooperative:
C12Q1/6886; C12Q2600/106; C12Q2600/156
- 其他
- Patent application
- ID号码
- 2301
- 国家/地区
- 德国
欲了解更多信息,请点击 这里